1. Home
  2. NBTX vs VABK Comparison

NBTX vs VABK Comparison

Compare NBTX & VABK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBTX
  • VABK
  • Stock Information
  • Founded
  • NBTX 2003
  • VABK 1998
  • Country
  • NBTX France
  • VABK United States
  • Employees
  • NBTX N/A
  • VABK 146
  • Industry
  • NBTX Biotechnology: Pharmaceutical Preparations
  • VABK Major Banks
  • Sector
  • NBTX Health Care
  • VABK Finance
  • Exchange
  • NBTX Nasdaq
  • VABK Nasdaq
  • Market Cap
  • NBTX 211.9M
  • VABK 221.3M
  • IPO Year
  • NBTX 2020
  • VABK N/A
  • Fundamental
  • Price
  • NBTX $9.70
  • VABK $41.05
  • Analyst Decision
  • NBTX Strong Buy
  • VABK
  • Analyst Count
  • NBTX 1
  • VABK 0
  • Target Price
  • NBTX $8.00
  • VABK N/A
  • AVG Volume (30 Days)
  • NBTX 15.1K
  • VABK 44.0K
  • Earning Date
  • NBTX 09-18-2025
  • VABK 10-16-2025
  • Dividend Yield
  • NBTX N/A
  • VABK 3.51%
  • EPS Growth
  • NBTX N/A
  • VABK 14.13
  • EPS
  • NBTX N/A
  • VABK 3.31
  • Revenue
  • NBTX N/A
  • VABK $56,012,000.00
  • Revenue This Year
  • NBTX N/A
  • VABK N/A
  • Revenue Next Year
  • NBTX $74.67
  • VABK N/A
  • P/E Ratio
  • NBTX N/A
  • VABK $12.40
  • Revenue Growth
  • NBTX N/A
  • VABK 7.97
  • 52 Week Low
  • NBTX $2.76
  • VABK $33.66
  • 52 Week High
  • NBTX $10.59
  • VABK $44.57
  • Technical
  • Relative Strength Index (RSI)
  • NBTX 62.98
  • VABK 56.13
  • Support Level
  • NBTX $8.03
  • VABK $40.07
  • Resistance Level
  • NBTX $9.14
  • VABK $41.98
  • Average True Range (ATR)
  • NBTX 0.56
  • VABK 2.01
  • MACD
  • NBTX -0.02
  • VABK -0.07
  • Stochastic Oscillator
  • NBTX 68.67
  • VABK 44.65

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

About VABK Virginia National Bankshares Corporation

Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses, and charitable organizations.

Share on Social Networks: